Literature DB >> 23713499

Should uncontrollable worry be removed from the definition of GAD? A test of incremental validity.

Lauren S Hallion1, Ayelet Meron Ruscio.   

Abstract

In its current instantiation in DSM-IV, a diagnosis of generalized anxiety disorder (GAD) requires the presence of excessive and uncontrollable worry. It has been proposed that the uncontrollability criterion be removed from future editions of the DSM, primarily on the basis of empirical and conceptual overlap between excessiveness and uncontrollability and a relative lack of research on uncontrollability. However, no research has directly investigated the incremental validity of the uncontrollability criterion-that is, the extent to which uncontrollability predicts important clinical information over and above excessiveness. This question was examined in a community sample of 126 adults diagnosed with GAD. After controlling for excessiveness, uncontrollability explained a significant proportion of additional variance in a variety of relevant clinical measures, including GAD severity, clinician-rated anxiety, number and severity of comorbid disorders, and use of psychotropic medication and psychotherapy. The results remained statistically significant even when other features of GAD were controlled. By contrast, excessiveness did not significantly predict any clinical measure over and above uncontrollability. These findings suggest that uncontrollability contributes to the validity of the GAD diagnosis and should be retained as a core feature of pathological worry.
© 2013 American Psychological Association

Entities:  

Mesh:

Year:  2013        PMID: 23713499     DOI: 10.1037/a0031731

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  10 in total

1.  The impact of uncontrollability beliefs and thought-related distress on ecological momentary interventions for generalized anxiety disorder: A moderated mediation model.

Authors:  Lucas S LaFreniere; Michelle G Newman
Journal:  J Anxiety Disord       Date:  2019-07-13

2.  Difficulty concentrating in generalized anxiety disorder: An evaluation of incremental utility and relationship to worry.

Authors:  Lauren S Hallion; Shari A Steinman; Susan N Kusmierski
Journal:  J Anxiety Disord       Date:  2017-11-04

3.  Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristics.

Authors:  M Burstein; K Beesdo-Baum; J-P He; K R Merikangas
Journal:  Psychol Med       Date:  2014-01-02       Impact factor: 7.723

4.  Clinical Significance of Individual GAD Symptoms in Later Life.

Authors:  Beyon Miloyan; Nancy A Pachana
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-09-16       Impact factor: 2.680

5.  Reliability and validity of the dimensional features of generalized anxiety disorder.

Authors:  Lauren A Rutter; Timothy A Brown
Journal:  J Anxiety Disord       Date:  2014-10-30

6.  Neural Processing of Cognitive Control in an Emotionally Neutral Context in Anxiety Patients.

Authors:  Nicola König; Sarah Steber; Anna Borowski; Harald R Bliem; Sonja Rossi
Journal:  Brain Sci       Date:  2021-04-26

7.  How Therapeutic Tapping Can Alter Neural Correlates of Emotional Prosody Processing in Anxiety.

Authors:  Nicola König; Sarah Steber; Josef Seebacher; Quinten von Prittwitz; Harald R Bliem; Sonja Rossi
Journal:  Brain Sci       Date:  2019-08-19

8.  Centrality and bridge symptoms of anxiety, depression, and sleep disturbance among college students during the COVID-19 pandemic-a network analysis.

Authors:  Yanqiang Tao; Wenxin Hou; Haiqun Niu; Zijuan Ma; Shuang Zhang; Liang Zhang; Xiangping Liu
Journal:  Curr Psychol       Date:  2022-08-03

9.  Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study.

Authors:  Víviam Vargas Barros; Emérita Sátiro Opaleye; Marcelo Demarzo; Sarah Bowen; Daniela Fernández Curado; Helena Hachul; Ana Regina Noto
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

10.  Comparative efficacy and safety of traditional Chinese patent medicine for anxiety disorders in children or adolescence: A protocol for systematic review and network meta-analysis.

Authors:  Zhenyuan Jiang; Jiahao Wang; Xiaowen Yu; Chuancheng Li; Yuze Shao; Zhonglin Wang
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.